AIDX HEALWELL AI INC

HEALWELL AI to Announce Fiscal First Quarter 2024 Financial Results on May 14, 2024

HEALWELL AI to Announce Fiscal First Quarter 2024 Financial Results on May 14, 2024

  • HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, May 14, 2024, at 5:00 pm EDT (2:00 pm PDT).

TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. ("HEALWELL" or the "Company") (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to announce the Company will release its Fiscal First Quarter 2024 financial results for the period ended March 31, 2024, on Tuesday, May 14, 2024. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 5:00 pm EDT (2:00 pm PDT). The call will be hosted by Dr. Alexander Dobranowski, Chief Executive Officer, and Scott Nirenberski, Chief Financial Officer. Please dial in 10 minutes prior to the start of the call.

Fiscal First Quarter 2024 Conference Call

Date: Tuesday, May 14, 2024

Time: 5:00 PM ET / 2:00 PM PT

For attendees who wish to join by webcast, the event can be accessed at:

Attendees who wish to join by phone must visit the following link and pre-register:

Instructions for joining by phone:

  1. Click on the call link and complete the online registration form.
  2. Upon registering you will receive the dial-in info and a unique PIN to join the call as well as an email confirmation with the details.
  3. Select a method for joining the call.
  4. Dial-In: A dial in number and unique PIN are displayed to connect directly from your phone.
  5. Call Me: Enter your phone number and click “Call Me” for an immediate callback from the system. The call will come from a US number.

Dr. Alexander Dobranowski

Chief Executive Officer

HEALWELL AI

About HEALWELL

HEALWELL is a healthcare technology company focused on AI and data science for preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange (the “TSX”) under the symbol “AIDX” and on the OTC Exchange under the symbol “HWAIF”. To learn more about HEALWELL, please visit .

For more information:

Pardeep Sangha

Investor Relations, HEALWELL AI Inc.

Phone:   604-572-6392

 



EN
10/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on HEALWELL AI INC

 PRESS RELEASE

HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Di...

HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot HEAWELL AI’s Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease (“CKD”) progression when paired with Electronic Health Record (“EHR”) linked clinical decision support, improves guideline-recommended testing in patients with CKD.HEALWELL’s subsidiary Khure Health (“Khure”) co-authored an abstract that was published this month in the American Journal...

 PRESS RELEASE

HEALWELL AI Reports Q1-2024 Financial Results

HEALWELL AI Reports Q1-2024 Financial Results HEALWELL AI achieved quarterly revenue from continuing operations of $4.58 million in Q1-2024, 132% higher compared to $1.97 million generated in Q1-2023 and 139% higher than $1.92 million generated in Q4-2023.Since its relaunch in Q4-2023 and its acquisition of Intrahealth, an enterprise class EHR service provider on February 1, 2024, the Company’s annual revenue run rate has more than doubled to over $20 million with the largest component of revenues now coming from SaaS and services.Management provides a positive outlook based on strong and a...

 PRESS RELEASE

HEALWELL AI to Announce Fiscal First Quarter 2024 Financial Results on...

HEALWELL AI to Announce Fiscal First Quarter 2024 Financial Results on May 14, 2024 HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, May 14, 2024, at 5:00 pm EDT (2:00 pm PDT). TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. ("HEALWELL" or the "Company") (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to announce the Company will release its Fiscal First Quarter 2024 financial results for the period ended March 31, 2024, on Tuesday, May 14, 2024. The Company will hold a conference call and simult...

 PRESS RELEASE

HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million

HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI INC. (“HEALWELL” or the “Company”) (TSX: AIDX) is pleased to announce today that, due to strong demand, it has agreed with Clarus Securities Inc. (“Clarus”) and Eight Capital Corp. (“Eight”), as Co-Bookrunners and Co-Lead Underwriters (the “Co-Lead Underwriters”), on behalf of a syndicate of underwriters (collectively, the “Underwriters”), to increase the size of its pre...

 PRESS RELEASE

HEALWELL AI Announces $16 Million Bought Deal Private Placement

HEALWELL AI Announces $16 Million Bought Deal Private Placement NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. ("HEALWELL" or the "Company") (TSX: AIDX), a data science and AI company focused on preventative care, is pleased to announce that it has entered into an agreement pursuant to which Clarus Securities Inc. and Eight Capital, as lead underwriters and co-bookrunners, together with a syndicate of underwriters (collectively, the “Underwriters”), will purchase 11,851,900 units of th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch